Aptahem AB (STU:94V) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:94V Aptahem AB STU:94V
30 GF Score
Price €0.07
! 2 Warning Signs
View Full Analysis

What is Aptahem AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:94V vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Aptahem AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptahem AB Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptahem AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Aptahem AB's Short Interest falls into.


STU:94V
30GF Score
Aptahem AB STU:94V
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptahem AB Business Description

Other Exchanges APTA:Sweden
Address Norra Vallgatan 58, Malmo, SWE, 211 22
Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.
30GF Score

Get the complete analysis for STU:94V

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.07
Price